Publicaciones en colaboración con investigadores/as de Instituto Cajal (7)

2019

  1. Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation

    Neurotherapeutics, Vol. 16, Núm. 3, pp. 808-827

2017

  1. A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice

    Neuropsychopharmacology, Vol. 42, Núm. 2, pp. 524-539

2015

  1. Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer’s disease

    Clinical Epigenetics, Vol. 7, Núm. 1

2012

  1. Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis

    Revista de Neurologia, Vol. 54, Núm. 2, pp. 114-124

2007

  1. Hypoxia transduction by carotid body chemoreceptors in mice lacking dopamine D2 receptors

    Journal of Applied Physiology, Vol. 103, Núm. 4, pp. 1269-1275

2006

  1. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis

    American Journal of Pathology, Vol. 168, Núm. 1, pp. 280-291

  2. Adrenomedullin: An Esoteric Juggernaut of Human Cancers

    Handbook of Biologically Active Peptides (Elsevier Inc.), pp. 453-458